Standard Cosentyx Dosing for Adults
Cosentyx (secukinumab) is dosed at 300 mg subcutaneously once weekly for the first 5 weeks (loading doses), then 300 mg every 4 weeks for plaque psoriasis, psoriatic arthritis, or ankylosing spondylitis. This fixed dose applies regardless of body weight in adults.[1]
Does Weight Affect Dosage?
No weight-based adjustments are recommended for adults. The 300 mg dose (two 150 mg injections) is standard for patients over 18 kg, with no increases for heavier weights like obesity. Clinical trials included patients up to 160 kg without dose changes.[1][2]
Dosing in Pediatric Patients
For kids 6+ years (plaque psoriasis, ≥15 kg):
- 75 mg (one 75 mg injection) every 4 weeks if 15-50 kg.
- 150 mg (one 150 mg or two 75 mg injections) every 4 weeks if >50 kg.
Loading doses match maintenance. No adjustments beyond these weight bands.[1]
Why No Adult Weight Adjustments?
Pivotal trials (e.g., SCULPTURE, FUTURE studies) showed consistent efficacy and pharmacokinetics across BMI ranges, including obese patients (BMI >30). Exposure levels remain therapeutic without escalation.[2][3]
What If I'm Obese?
Real-world data and FDA labeling confirm no dose increase needed. Some studies note slightly lower response rates in BMI >30, but guidelines stick to 300 mg. Consult a doctor for monitoring.[2][4]
Injection Tips for Larger Patients
Use proper technique: pinch skin, inject into thigh, abdomen, or upper arm. Heavier patients may need longer needles (e.g., 12.7 mm pen) if subcutaneous fat is thick, but dose volume stays the same.[1]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Label for Cosentyx
[3]: Clinical Pharmacology Review - Secukinumab
[4]: JAAD Study on Obesity and Biologics Response